Controversy over microbiome-based cancer diagnostic study; Seeking answers to racial disparities

Alleged "fatal errors" in a high-profile Nature paper could mean trouble for biotech Micronoma's flagship liquid biopsy technology.

August 4, 2023 Check out STAT+

Sponsored By

Antibiotic Resistance Coordination and Strategy Unit/CDC STAT+ | Study proposing microbiome-based cancer diagnostic comes under fire A controversy over a high-profile Nature paper's findings could have big implications for the scientific foundation of biotech Micronoma. By Angus Chen and Matthew Herper STAT+ | White House drug shortage task force held rare in-person meeting with industry A new White House task force held a rare in-person meeting Friday to brainstorm policies for stemming shortages of cancer drugs. By John Wilkerson Opinion: Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff Infections play a primary or secondary role in the death of roughly half of patients with some types of cancer. By Helen W. Boucher and Kevin Outterson Courtesy Fox Chase Cancer Center Researchers seek answers to racial disparities for prostate and breast cancer among people of African ancestry A new global study is trying to understand why Black men and women are at a higher risk of developing and dying from aggressive prostate or breast cancer. By Deborah Balthazar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser